Exploring the therapeutic implications of natural compounds modulating apoptosis in vascular dementia

Guangcheng Zhong1, Xinyue Wang2,3, Qian Zhang1

  • 1Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.

Phytotherapy Research : PTR
|September 3, 2024
PubMed

Insights

Vascular dementia (VaD) involves brain cell death (apoptosis). Natural compounds show promise in protecting brain cells, offering potential new treatments for VaD.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Vascular dementia (VaD) is a common form of dementia linked to cerebrovascular disease, causing memory and executive function deficits.
  • Current treatments for VaD are limited due to its complex development, highlighting the need for novel therapeutic strategies.
  • Apoptosis, or programmed cell death, plays a significant role in VaD pathogenesis, making it a key target for intervention.

Purpose of the Study:

  • To explore the molecular mechanisms of apoptosis in relation to VaD.
  • To review the neuroprotective effects of natural compounds on VaD by modulating apoptosis.
  • To provide a reference for developing new VaD pharmaceuticals.

Main Methods:

  • Systematic review of existing research on apoptosis and VaD.
  • Analysis of molecular pathways involved in apoptosis relevant to VaD.
  • Evaluation of studies on natural compounds with potential therapeutic effects on VaD.

Main Results:

  • Evidence suggests apoptosis significantly contributes to VaD onset and progression.
  • Numerous natural compounds have demonstrated neuroprotective potential by regulating apoptosis in VaD models.
  • Understanding apoptosis mechanisms is crucial for identifying effective VaD treatments.

Conclusions:

  • Natural compounds targeting apoptosis represent a promising avenue for VaD treatment development.
  • Further rigorous clinical trials are necessary to confirm the efficacy and safety of these compounds for VaD.
  • This review serves as a foundation for future research into natural product-based VaD therapies.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454